Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
Editorial Group: Cochrane Airways Group
Published Online: 19 JUL 2006
Assessed as up-to-date: 23 MAR 2006
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Appleton S, Poole P, Smith BJ, Veale A, Lasserson TJ, Chan MMK, Cates CJ. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001104. DOI: 10.1002/14651858.CD001104.pub2.
- Publication Status: Stable (no update expected for reasons given in 'What's new')
- Published Online: 19 JUL 2006
Current VersionLong-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
Sarah Appleton, Phillippa Poole, Brian J Smith, Antony Veale, Toby J Lasserson, Matthew Ming Ki Chan and Christopher J Cates
Article first published online: 19 JUL 2006 | DOI: 10.1002/14651858.CD001104.pub2
Previous versions of this article and their online publication dates
Version 1Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation
S Appleton, P Poole, B Smith, C Cates, A Veale and A Bara
Article first published online: 23 OCT 2001 | DOI: 10.1002/14651858.CD001104